Related Experiment Video
Updated: Jul 10, 2026
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
A data-driven computational model of the ErbB receptor signaling network.
Birgit Schoeberl1, Emily Pace, Shavonne Howard
1Merrimack Pharmaceuticals, Cambridge, MA 02141, USA.
Summary
This study develops quantitative, cell-type specific models for cell signaling, addressing how different cell types respond uniquely. It integrates protein array data and mathematical modeling for ErbB receptor family signaling.
Area of Science:
- Cellular signaling and systems biology.
- Quantitative biological modeling.
- Receptor tyrosine kinase signaling.
Background:
- Qualitative models of signal transduction networks often overlook cell-type specific differences.
- Cellular responses to signaling pathways vary significantly across different cell types, even with conserved network topology.
- Existing models struggle to capture the quantitative nuances of cell-specific signaling.
Purpose of the Study:
- To develop quantitative, cell-type specific models for cell signaling.
- To integrate experimental data from protein arrays and mathematical modeling.
- To investigate the controversial signaling mechanisms of the ErbB receptor family.
Main Methods:
- Utilizing protein array data for quantitative measurements.
- Employing mathematical modeling to construct cell-type specific signaling models.
- Focusing on the ErbB receptor family as a case study due to conflicting literature.
Main Results:
- Demonstrated the feasibility of creating quantitative, cell-type specific signaling models.
- Successfully applied the approach to the ErbB receptor family, providing new insights.
- Highlighted the importance of cell-type specificity in understanding signaling network dynamics.
Conclusions:
- Quantitative, cell-type specific models are essential for accurately representing cell signaling.
- The developed methodology offers a framework for building such models across various signaling pathways.
- Further research into ErbB receptor family signaling can benefit from this quantitative, cell-specific approach.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...